Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H6FNO |
| Molecular Weight | 139.127 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=CC=C(F)C=C1
InChI
InChIKey=VNDHYTGVCGVETQ-UHFFFAOYSA-N
InChI=1S/C7H6FNO/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,(H2,9,10)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. | 2010-09 |
|
| 4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: drug-like and non-xanthine based A2B adenosine receptor antagonists. | 2010-07-15 |
|
| Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. | 2010-05 |
|
| Importance of extracellular loop one of the neuropeptide S receptor for biogenesis and function. | 2010-01 |
|
| Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy. | 2010 |
|
| Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors. | 2009-03-18 |
|
| Raltegravir in the management of HIV-infected patients. | 2009-02-06 |
|
| [New derivatives of eremomycin containing (15)n or f atoms for NMR study]. | 2008-12-18 |
|
| Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. | 2008-06 |
|
| Raltegravir: first in class HIV integrase inhibitor. | 2008-04 |
|
| From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety. | 2007-01-15 |
|
| 19F NMR chemical shifts induced by a helical peptide. | 2006-07 |
|
| A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells. | 2005-10-15 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60231717
Created by
admin on Mon Mar 31 19:16:59 GMT 2025 , Edited by admin on Mon Mar 31 19:16:59 GMT 2025
|
PRIMARY | |||
|
824-75-9
Created by
admin on Mon Mar 31 19:16:59 GMT 2025 , Edited by admin on Mon Mar 31 19:16:59 GMT 2025
|
PRIMARY | |||
|
212-535-9
Created by
admin on Mon Mar 31 19:16:59 GMT 2025 , Edited by admin on Mon Mar 31 19:16:59 GMT 2025
|
PRIMARY | |||
|
102765
Created by
admin on Mon Mar 31 19:16:59 GMT 2025 , Edited by admin on Mon Mar 31 19:16:59 GMT 2025
|
PRIMARY | |||
|
YB79F3XB1G
Created by
admin on Mon Mar 31 19:16:59 GMT 2025 , Edited by admin on Mon Mar 31 19:16:59 GMT 2025
|
PRIMARY | |||
|
71572
Created by
admin on Mon Mar 31 19:16:59 GMT 2025 , Edited by admin on Mon Mar 31 19:16:59 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
